Edgewell Personal Care Co Dossier
|
SectorConsumer Staples IndustryHousehold & Personal Products Beta (adjusted)0.58 Intrinsic Value $34.28median of 3 methodsbased on filings through 30 Jun 2026 Market Price $26.67Price as of 1 Oct 2026 UndervaluedIntrinsic value is 29% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $1.2B Enterprise Value $2.1B Shares Outstanding 46M diluted Moat Rating None Next Earnings Date12 Nov 2026 Last ex-dividend9 Sep 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Edgewell Personal Care is undergoing a significant structural transformation, highlighted by its strategic decision to divest its lower-margin Feminine Care business to Essity. This divestiture is intended to reshape Edgewell into a leaner, more agile, and consumer-focused personal care company centered on its high-margin Wet Shave, Sun Care, and Men's Grooming segments (such as Cremo). However, near-term performance remains heavily pressured by inflationary headwinds, incremental tariffs, and volume declines in North American operations. While the long-term outlook is supported by productivity initiatives and debt reduction, current macroeconomic challenges and flat organic growth justify a Hold rating until margin recovery and volume stabilization consistently materialize. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$29.00 Mean target$32.17 High · most bullish analyst$35.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario The bear case reflects prolonged volume declines in North American Wet Shave and Sun Care operations due to intense competitive pricing pressures from major players like Procter & Gamble. Persistent inflation in shipping and raw material costs, combined with execution delays in factory consolidation, continues to compress operating margins, keeping profitability depressed. Base CaseCentral scenario The base case assumes Edgewell successfully completes its Feminine Care divestiture and utilizes the proceeds to pay down debt and execute opportunistic share buybacks. Organic sales growth is expected to remain flat to slightly positive in fiscal 2026 before recovering to moderate growth in fiscal 2027. Restructuring benefits and cost-saving initiatives are projected to offset tariff headwinds, leading to sequential margin improvement in the second half of fiscal 2026. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |